Wei‐Kwang Luk
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- Animal Science and Zoology top 1%
- Animal Virus Infections Studies
Papers in
-
- Respiratory viral infections research 3
-
- Viral gastroenteritis research and epidemiology 2
- Amoebic Infections and Treatments 2
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Kwok‐Yung Yuen (10 shared papers)Patrick C. Y. Woo (8 shared papers)Susanna K. P. Lau (5 shared papers)Rosana Wing‐Shan Poon (3 shared papers)Kwok‐Hung Chan (3 shared papers)Chung‐Ming Chu (2 shared papers)Yi Huang (2 shared papers)Hoi‐Wah Tsoi (2 shared papers)
- Journals
- Journal of Clinical Microbiology (3 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Clinical Infectious Diseases (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Journal of Clinical Virology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wei‐Kwang Luk
18 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 1.3k
- Animal Science and Zoology 450
- Molecular Medicine 133
- Endocrinology 97
- Epidemiology 640
Countries citing papers authored by Wei‐Kwang Luk
This map shows the geographic impact of Wei‐Kwang Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Kwang Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Kwang Luk more than expected).
Fields of papers citing papers by Wei‐Kwang Luk
This network shows the impact of papers produced by Wei‐Kwang Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Kwang Luk. The network helps show where Wei‐Kwang Luk may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Kwang Luk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia Hit paper breakdown → | 2004 | 1102 |
| 2 | 2005 | 190 | |
| 3 | 1999 | 96 | |
| 4 | 2004 | 74 | |
| 5 | 2006 | 64 | |
| 6 | 2018 | 59 | |
| 7 | 2017 | 42 | |
| 8 | 2013 | 36 | |
| 9 | 2003 | 36 | |
| 10 | 2016 | 31 | |
| 11 | 1998 | 29 | |
| 12 | 2011 | 21 | |
| 13 | 2014 | 16 | |
| 14 | 2017 | 12 | |
| 15 | 2017 | 7 | |
| 16 | 1998 | 3 | |
| 17 | 2015 | 2 | |
| 18 | Ultrasound-guided thrombin injection for pseudoaneurysms: a case series at a local hospital. | 2012 | 1 |
About Wei‐Kwang Luk
Wei‐Kwang Luk is a scholar working on Epidemiology, Infectious Diseases, Endocrinology, Molecular Medicine and Surgery, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Respiratory viral infections research (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Streptococcal Infections and Treatments (2 papers), Amoebic Infections and Treatments (2 papers), Infections and bacterial resistance (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Animal Science and Zoology (450 citations), Molecular Medicine (133 citations), Endocrinology (97 citations) and Epidemiology (640 citations). Wei‐Kwang Luk has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Kwok‐Yung Yuen, Patrick C. Y. Woo, Susanna K. P. Lau, Rosana Wing‐Shan Poon, Kwok‐Hung Chan, Chung‐Ming Chu, Yi Huang, Hoi‐Wah Tsoi, Yi Guan and Beatrice H. L. Wong. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.